IRCT20210809052117N1
Not yet recruiting
Phase 3
Effect of Empagliflozin on clinical and echocardiographic parameters in non diabetic patient with reduced LVEF heart failure
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 44
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age: 18 yr\_80 yr
- •Heart failure with reduced EF \<40%
- •Nondiabetic
- •Stable symptom and therapy for heart failure
Exclusion Criteria
- •Cardiovascular event, admission for cardiovascular or renal complications within last 3 months
- •Cancer or life\-threatening condition
- •Estimated GFR \< 45 ml/min/m2
- •Systolic blood pressure \< 90mmhg
- •Pregnancy or lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarctionTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
Not yet recruiting
Phase 2
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary arteryacute myocardial infarction.121-09IRCT20200727048226N1Tehran University of Medical Sciences88
Active, not recruiting
Phase 1
Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failurediabetes mellitus and heart failureMedDRA version: 20.0Level: LLTClassification code 10011949Term: Decompensation cardiacSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2019-002202-43-ITAOU FEDERICO II34
Not yet recruiting
Phase 4
To Study the effect of Empagliflozin on the cardiovascular biomarkers in diabetic patients myocardial infarctioCondition 1: Myocardial Infarction. Condition 2: Type 2 diabetes.Acute transmural myocardial infarction of unspecified siteType 2 diabetes mellitus without complicationsI21.3E11.9IRCT20230724058910N1Zanjan University of Medical Sciences60
Recruiting
Phase 2
The effect of Empagliflozin on left ventricular ejection fraction in non-diabetic patients with acute anterior ST elevation Myocardial infarction treated with primary PCIAcute anterior ST elevation Myocardial infarction treated with primary PCI.ST elevation (STEMI) myocardial infarction of anterior wallI21.0IRCT20221227056950N1Mashhad University of Medical Sciences64